Best Practices for Interventional Cardiovascular Medical Device Trials in APAC, Upcoming Webinar Hosted by Xtalks
TORONTO (PRWEB) September 17, 2019 -- The Asia-Pacific region (APAC) is prepared to be key in addressing one of the world’s great health concerns. In our aging society, heart disease has become one of the most significant health problems worldwide. Its incidence is forecast to increase steadily as the number of people aged 60 and older is expected to double by 2025 and to triple by 2050. This aging will occur disproportionately in the Asia-Pacific region, which is predicted to account for half of the world’s cardiovascular disease burden by mid-century. This disease’s migration signals the need to anticipate and leverage the region’s role in therapeutic development and clinical trials.
The demographic shift and other factors point to the fast-growing region — which is expected to surpass the European Union in 2020 as the world’s second-largest med-tech market (after the United States) —becoming a major force in cardiovascular clinical trials.
Bringing interventional cardiac devices to market is a large and complex opportunity, and sponsors seeking to bring implantable cardiovascular products to the APAC market face significant challenges in designing and conducting clinical trials for stents, valves, pacemakers, ventricular assist devices and novel technologies.
Join Premier Research experts — Sundeep Shrivastava, Executive Director of Strategic Development, Medical Device & Diagnostics, APAC and Joanne Emmett, Vice President of Medical Device & Diagnostics — in a live webinar on Tuesday, October 1, 2019 at 11am EDT (4pm BST/UK) to learn about:
- Opportunities and challenges in clinical investigation of medical devices
- The impact of a changing regulatory environment
- Considerations in study conduct such as treatment protocols, data, endpoints and selection of principal investigators, sites and patients
- Reimbursement strategies
- Vendor selection
For more information or to register for this event, visit Best Practices for Interventional Cardiovascular Medical Device Trials in APAC.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Candice Tang, Xtalks, http://www.xtalks.com, 1 (416) 977-6555, [email protected]
Share this article